Repositioning Candidate Details
| Candidate ID: | R0834 |
| Source ID: | DB05562 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Naluzotan |
| Synonyms: | Naluzotan |
| Molecular Formula: | C23H38N4O3S |
| SMILES: | CC(=O)NC1=CC=CC(=C1)N1CCN(CCCCNS(=O)(=O)CC2CCCCC2)CC1 |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 740873-06-7 |
| Molecular Weight: | 450.64 |
| DrugBank Indication: | Investigated for use/treatment in anxiety disorders and depression. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | 5-hydroxytryptamine receptor 1A agonist |
| Inclusion Criteria: | Indication associated |
